Rilexine 200 LC
Rilexine 200 LC
Authorised
- Cefalexin monohydrate
Product identification
Medicine name:
Rilexine 200 LC
Active substance:
- Cefalexin monohydrate
Target species:
-
Cattle (dairy cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cefalexin monohydrate210.40/milligram(s)1.00Applicator
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dairy cow)
-
Meat and offal4day
-
Milk3day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51DB01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Federal Office Of Consumer Protection And Food Safety
Authorisation number:
- 400144.00.00
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 10/01/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
German (PDF)
Published on: 10/01/2025
How useful was this page?:
